Benefits and risks of therapeutic alternatives for macrolide resistant Mycoplasma pneumoniae pneumonia in children

Although Mycoplasma pneumoniae pneumonia (MPP) has been generally susceptible to macrolides, the emergence of macrolide-resistant MPP (MRMP) has made its treatment challenging. MRMP rapidly spread after the 2000s, especially in East Asia. MRMP is more common in children and adolescents than in adult...

Descripción completa

Detalles Bibliográficos
Autor principal: Yang, Hyeon-Jong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Pediatric Society 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584239/
https://www.ncbi.nlm.nih.gov/pubmed/30999732
http://dx.doi.org/10.3345/kjp.2018.07367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584239/
https://www.ncbi.nlm.nih.gov/pubmed/30999732
http://dx.doi.org/10.3345/kjp.2018.07367

Ejemplares similares